Potentially Modifiable Dementia Risk Factors in Canada: An Analysis of Canadian Longitudinal Study on Aging with a
1Manuel Montero-Odasso, Departments of Medicine (Geriatrics) and Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, University of Western Ontario, 500 Wellington Road, London, ON, Canada, N6C 0A7, mmontero@uwo.ca.
The Journal of Prevention of Alzheimer'S Disease
|October 1, 2024
Summary
Nearly half of dementia cases in Canada are linked to 12 modifiable risk factors. Addressing physical inactivity, hearing loss, obesity, and hypertension is key for dementia prevention strategies.
Area of Science:
- Neurology
- Public Health
- Epidemiology
Background:
- Estimates suggest up to 40% of global dementia cases are linked to modifiable risk factors, but this data is lacking for Canada.
- Sleep disturbances represent an emerging risk factor not yet integrated into life-course dementia prevention models.
Purpose of the Study:
- To determine the population impact of 12 modifiable risk factors, including sleep disturbances, on Canadian adults.
- To analyze these impacts by sex and age groups and compare findings with international data.
Main Methods:
- Analysis of baseline data from the Canadian Longitudinal Study on Aging (CLSA).
- Cross-sectional study involving 30,097 Canadian adults aged 45 and older.
- Examined Population Attributable Fractions (PAFs) for factors like physical inactivity, hearing loss, obesity, hypertension, and sleep disturbances.
Main Results:
- Physical inactivity (10.2%), hearing loss (6.5%), obesity (6.4%), and hypertension (6.2%) were the leading risk factors in midlife/later life.
- Sleep disturbances accounted for 3.0% of dementia cases.
- The 12 modifiable risk factors collectively explained approximately 52% of dementia cases in both men and women, with a combined PAF of 49.2% overall, increasing with age.
Conclusions:
- Close to 50% of dementia cases in Canada are attributable to 12 modifiable risk factors across the lifespan.
- Canadian dementia risk reduction initiatives should prioritize interventions targeting physical inactivity, hearing loss, obesity, and hypertension.
Related Concept Videos
Longitudinal Research
11.9K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
11.9K
Dementia
99
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
99
Longitudinal Studies
141
Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
141
Coronary Artery Disease I: Introduction
3
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
3
Alzheimer's Disease: Overview
451
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
451
Genome-wide Association Studies-GWAS
13.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.2K


